TICKERNERD
Menu
MDAIMDAIHealthcare · Medical Devices

MDAI Stock Forecast: Spectral AI, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$1.60
+2.56% on the day

The 1 Wall Street analysts covering Spectral AI, Inc. hold a median 12-month price target of $5.13 — +220.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 15 of 100 as at 11 Sept 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$51.5M
Ticker Nerd rank
15 / 100
Median analyst target
$5.13
Analysts covering
1
Revenue$3.5M−30.4% y/y
Operating income−$4.3M
Net income−$4.2M
Free cash flow−$4.1M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+2.6%
1M
−6.4%
YTD
+12.7%
1Y
−19.6%
From 52W high
−40.3%
From 52W low
+33.3%
$1.20
$2.68
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

MDAI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Spectral AI, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 11 Sept 2026
15 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
82
Revisions
49
Quality
42
Growth
33
Volatility
27
Value
26
Accruals
18
Momentum
18
Issuance
6

Size (82): Smaller than most of the companies we track.

Issuance (6): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

MDAI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on MDAI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.00$2.00$3.00$4.00$5.00$6.00$7.00Oct 25Jan 26Apr 26Jul 26MDAIHigh $6.25Median $5.13Low $4.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts
1 Buy0 Hold0 Sell
Low $4.00Median $5.13High $6.25

The green dot is the last close — the median target sits +220.3% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
27 May 2026BTIGMaintainsBuy$3.00 → $4.00
26 May 2026BTIGMaintainsBuy$3.00 → $4.00
25 Mar 2026BTIGReiteratesBuy—
10 Feb 2026BTIGReiteratesBuy—
12 Nov 2025BTIGMaintainsBuy—
2 Apr 2025HC Wainwright & Co.ReiteratesBuy—
18 Mar 2025HC Wainwright & Co.ReiteratesBuy—
13 Aug 2024HC Wainwright & Co.ReiteratesBuy—
12 Aug 2024Northland Capital MarketsInitiatesOutperform—
18 July 2024HC Wainwright & Co.InitiatesBuy—
23 Jan 2024BTIGInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MDAI appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

MDAI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Spectral AI, Inc. returned −19.6% against +17.5% for the S&P 500, dividends included.

MDAI vs S&P 500, last 12 monthsTotal return, rebased to 100
6080100120140Oct 25Jan 26Apr 26Jul 26MDAIS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

MDAI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

Spectral AI, Inc. (MDAI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
29.7×

Cheaper than 26% of US stocks

Price / sales
3.3×

Cheaper than 38% of US stocks

Price / book
−4.3×

Cheaper than 96% of US stocks

EV / EBITDA
−4.6×

Cheaper than 78% of US stocks

Growth & margins
Revenue growth (YoY)
−30.4%

Higher than 9% of US stocks

Earnings growth (YoY)
−30.4%

Higher than 16% of US stocks

Gross margin
31.6%

Higher than 36% of US stocks

Operating margin
−122.7%

Higher than 13% of US stocks

Net margin
−65.5%

Higher than 8% of US stocks

Returns & dividend
Return on equity
132.2%

Higher than 97% of US stocks

Return on assets
−41.9%

Higher than 10% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Spectral AI, Inc. (MDAI) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Spectral AI, Inc. has a market value of $51.5M and an enterprise value of $53.8M.

  • Revenue in the twelve months to 30 June 2026: $15.4M. The latest quarter shrank 30.4% year on year.

  • Net income over the same four quarters: −$10.1M, a −65.5% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.35.

  • Free cash flow in the twelve months to 30 June 2026: −$12.9M.

  • Shares outstanding: 32.2M.

  • Trailing P/E: 29.7×; forward P/E: −1.7× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Spectral AI, Inc. employs 65 people — $237K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 12 Sept 2026

Data provided by Twelve Data

Peers

MDAI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
MDAISpectral AI, Inc.$51.5M
15
XTNTXtant Medical Holdings, Inc.$48.5M
72
MYOMyomo, Inc.$51.5M
53
SRTSSensus Healthcare, Inc.$51.8M
51
BDMDBaird Medical Investment Holdings Ltd.$46.4M
19
TELATELA Bio, Inc.$43.2M
31
NNOXNano-X Imaging Ltd.$56.9M
19

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Spectral AI, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest MDAI news & analysis

Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewsWire · 1 Sept 2026neutral

Spectral AI, Inc. (Nasdaq: MDAI) announced that CEO Vincent Capone and CFO David McGuire are scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference. The announcement was made by the company on September 1, 2026, via GlobeNewsWire.

Why it matters — A MDAI watcher would care because the company's leadership presenting at a major investment conference provides an opportunity to showcase its AI-driven wound-care diagnostics platform to investors and the broader financial community.

Spectral AI, Inc. (MDAI) Q2 2026 Earnings Call Transcript

Seeking Alpha · 12 Aug 2026neutral

Spectral AI, Inc. (MDAI) released the transcript of its Q2 2026 earnings call, published by Seeking Alpha. The item reports on the company's second-quarter 2026 earnings call taking place.

Why it matters — The earnings call transcript provides MDAI watchers with a record of what management communicated about the company's Q2 2026 results and outlook.

Spectral AI Q2 Earnings Call Highlights

MarketBeat · 11 Aug 2026neutral

Spectral AI reported second-quarter results marking a transition toward commercial operations following the FDA's De Novo clearance of its DeepView System for burn assessment in May. The company reiterated its 2026 revenue guidance of approximately $18.5 million, which does not assume significant revenue from DeepView system sales.

Why it matters — A MDAI watcher would care because the earnings call confirms the company's shift from development to commercial operations and reaffirms its forward revenue guidance following regulatory clearance.

Spectral AI Announces 2026 Second Quarter Financial Results

GlobeNewsWire · 11 Aug 2026positive

Spectral AI reported its Q2 2026 financial results, highlighting a cash position of $14.0 million as of June 30, 2026, and said it is continuing to advance toward first commercial sales of its DeepView System for burn indication.

Why it matters — The update signals Spectral AI's financial stability and commercial progress toward launching its lead product, the DeepView System, which is a key milestone for the company.

Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call

GlobeNewsWire · 29 July 2026neutral

Spectral AI announced it will release its second quarter 2026 financial results on August 11, 2026 after market close, and will hold a conference call at 5:00 pm ET that same day to discuss the results.

Why it matters — The announcement provides the date and time for the company's quarterly financial update and investor call, which shareholders and analysts will watch for updates on Spectral AI's performance and outlook.

FAQ

Frequently asked questions about MDAI stock

What is the MDAI stock price forecast for 2026-2027?

The 1 Wall Street analysts covering Spectral AI, Inc. have a median 12-month price target of $5.13, with estimates ranging from $4 to $6.25. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is MDAI stock a buy right now?

Of the 1 analysts covering Spectral AI, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Spectral AI, Inc. 15 out of 100 across roughly 4,600 US stocks as at 11 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank MDAI?

As at 11 Sept 2026, Spectral AI, Inc. ranks 15 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (82 of 100).

Will MDAI stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +220.3% from the last close, and Ticker Nerd's factor model ranks Spectral AI, Inc. 15 out of 100 as at 11 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the MDAI stock forecast for 2030?

No analyst covering Spectral AI, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MDAI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $4 to $6.25 over the next 12 months.

How has MDAI stock performed over the past year?

Spectral AI, Inc. returned -19.6% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Spectral AI, Inc. do?

Spectral AI Inc. Class A Common Stock represents Spectral AI Inc., an artificial intelligence company focused on predictive medical diagnostics for wound care.

What is the latest news on MDAI?

The most recent item we track (GlobeNewsWire, 1 Sept 2026): "Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference". Spectral AI, Inc. (Nasdaq: MDAI) announced that CEO Vincent Capone and CFO David McGuire are scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference. The announcement was made by the company on September 1, 2026, via GlobeNewsWire.

Company

About Spectral AI, Inc.

Spectral AI Inc. Class A Common Stock represents Spectral AI Inc., an artificial intelligence company focused on predictive medical diagnostics for wound care. The company’s DeepView platform is designed to help clinicians assess wound healing potential before treatment by using proprietary AI and multispectral imaging to distinguish between damaged and healthy tissue. Its current work centers on supporting faster, more objective treatment decisions in burn care and diabetic foot ulcer applications, with additional clinical uses in development. Spectral AI serves the healthcare technology market by combining imaging, software, and diagnostic analysis into tools intended for physician use in hospital and clinical settings. Headquartered in Dallas, Texas, Spectral AI operates as a specialized medical technology business within the broader digital health and medical devices sector.

CEO Mr. Vincent Stanley Capone Esq. · 65 employees · United States · https://www.spectral-ai.com